Travere Therapeutics (TVTX) Shares Outstanding (Diluted) (2013 - 2026)
Travere Therapeutics' Shares Outstanding (Diluted) was 93.48 million in Q2 2026, up 5.1% from 88.95 million a year earlier and up 1.8% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Travere Therapeutics came in at 89.21 million, up 13.1% from FY2024.
- Shares Outstanding (Diluted) has now increased for 12 consecutive years, with a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 78.89 million in FY2024 (+6.2%), 74.27 million in FY2023 (+16.5%), 63.76 million in FY2022 (+6.6%) and 59.83 million in FY2021 (+25.9%).
- Quarterly Shares Outstanding (Diluted) has moved between 59.83 million (Q4 2021) and 102.62 million (Q3 2025) over five years.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 39 straight quarters, with growth averaging 11.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 1.9% in Q3 2024 to 31.9% in Q3 2025.
- Per Business Quant data, TVTX's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 91.87 million (Q1 2026), 89.21 million (Q4 2025) and 102.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Travere Therapeutics | 5.36 Bn | 4.96 Bn | 167.41 Mn | 93.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.48 Mn |
| Mar 31, 2026 | 91.87 Mn |
| Dec 31, 2025 | 89.21 Mn |
| Sep 30, 2025 | 102.62 Mn |
| Jun 30, 2025 | 88.95 Mn |
| Mar 31, 2025 | 88.36 Mn |
| Dec 31, 2024 | 78.89 Mn |
| Sep 30, 2024 | 77.78 Mn |
| Jun 30, 2024 | 77.50 Mn |
| Mar 31, 2024 | 77.14 Mn |
| Dec 31, 2023 | 74.27 Mn |
| Sep 30, 2023 | 76.31 Mn |
| Jun 30, 2023 | 76.00 Mn |
| Mar 31, 2023 | 68.17 Mn |
| Dec 31, 2022 | 63.76 Mn |
| Sep 30, 2022 | 64.03 Mn |
| Jun 30, 2022 | 63.64 Mn |
| Mar 31, 2022 | 63.13 Mn |
| Dec 31, 2021 | 59.83 Mn |
| Sep 30, 2021 | 60.80 Mn |
API Access
Travere Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();